S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
This 11% Dividend Stock Has 11%+ Upside, Too
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
This 11% Dividend Stock Has 11%+ Upside, Too
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
This 11% Dividend Stock Has 11%+ Upside, Too
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
This 11% Dividend Stock Has 11%+ Upside, Too
TSE:TH

Theratechnologies - TH Stock Forecast, Price & News

C$1.34
+0.06 (+4.69%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
C$1.26
C$1.37
50-Day Range
C$1.13
C$2.93
52-Week Range
C$1.03
C$4.12
Volume
25,134 shs
Average Volume
23,229 shs
Market Capitalization
C$127.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.25
TH stock logo

About Theratechnologies (TSE:TH) Stock

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Open Letter to Shareholders from CEO Paul Levesque
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
See More Headlines
Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Company Calendar

Today
2/05/2023
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
87
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$3.25
High Stock Price Forecast
C$3.25
Low Stock Price Forecast
C$3.25
Forecasted Upside/Downside
+142.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$77.39 million
Cash Flow
C$0.36 per share
Book Value
C($0.19) per share

Miscellaneous

Free Float
N/A
Market Cap
C$127.49 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Paul Lévesque (Age 59)
    Pres, CEO & Director
    Comp: $1.24M
  • Mr. Philippe Dubuc M.B.A. (Age 56)
    MBA, Sr. VP & CFO
    Comp: $393.59k
  • Dr. Christian Marsolais Ph.D. (Age 60)
    Sr. VP & Chief Medical Officer
    Comp: $383.71k
  • Mr. John Leasure (Age 58)
    Global Commercial Officer
    Comp: $353.81k
  • Ms. Elif McDonald
    Sr. Director of Investor Relations
  • Mr. Jocelyn Lafond L.L.M. (Age 55)
    LL.B., Gen. Counsel & Corp. Sec.
  • Mr. Denis Boucher B.A. (Age 57)
    L.L.B., VP of Communications & Corp. Affairs
  • Hon. Andre Dupras M.Sc. (Age 59)
    VP of HR













TH Stock - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TH shares.
View TH analyst ratings
or view top-rated stocks.

What is Theratechnologies' stock price forecast for 2023?

3 brokerages have issued 1-year target prices for Theratechnologies' stock. Their TH share price forecasts range from C$3.25 to C$3.25. On average, they expect the company's stock price to reach C$3.25 in the next twelve months. This suggests a possible upside of 142.5% from the stock's current price.
View analysts price targets for TH
or view top-rated stocks among Wall Street analysts.

How have TH shares performed in 2023?

Theratechnologies' stock was trading at C$1.20 at the start of the year. Since then, TH stock has increased by 11.7% and is now trading at C$1.34.
View the best growth stocks for 2023 here
.

When is Theratechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TH earnings forecast
.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), Theratechnologies (THERF), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Endeavour Mining (EDV), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).

What is Theratechnologies' stock symbol?

Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Theratechnologies' stock price today?

One share of TH stock can currently be purchased for approximately C$1.34.

How much money does Theratechnologies make?

Theratechnologies (TSE:TH) has a market capitalization of C$127.49 million and generates C$77.39 million in revenue each year.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The official website for the company is www.theratech.com. The company can be reached via phone at +1-514-3367800.

This page (TSE:TH) was last updated on 2/5/2023 by MarketBeat.com Staff